Treatment
ÎIn patients who have UEDVT that is associated with a central venous catheter that is removed, the ACCP recommends 3 months of anticoagulation over a longer duration of therapy in patients with no cancer (1-B), and the ACCP suggests this in patients with cancer (2-C).
ÎIn patients who have UEDVT that is associated with a central venous catheter that is not removed, the ACCP recommends that anticoagulation is continued as long as the central venous catheter remains over stopping after 3 months of treatment in patients with cancer (1-C), and the ACCP suggests this in patients with no cancer (2-C).
ÎIn patients who have UEDVT that is not associated with a central venous catheter or with cancer, the ACCP recommends 3 months of anticoagulation over a longer duration of therapy (1-B).
ÎIn patients with acute symptomatic UEDVT, the ACCP suggests compression sleeves or venoactive medications NOT be used (2-C).
12
